We are live on ! Find out more
CSPIA

Cary Street Partners Investment Advisory Portfolio holdings

AUM $494M
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
-12.01%
1 Year Est. Return
+27.12%
3 Year Est. Return
+84.09%
5 Year Est. Return
+94.67%
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$816M
Cap. Flow
+$919M
Cap. Flow %
77.84%
Top 10 Hldgs %
18.45%
Holding
567
New
294
Increased
201
Reduced
42
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 14.69%
2 Healthcare 11.98%
3 Financials 9.01%
4 Consumer Staples 5.37%
5 Industrials 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGS icon
476
ONE Gas
OGS
$5.05B
$136K 0.01%
+1,669
New +$143K
IHIT
477
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$133K 0.01%
15,510
+2,500
+19% +$21.6K
ARCC icon
478
Ares Capital
ARCC
$14.3B
$132K 0.01%
+7,350
New +$145K
ESGE icon
479
iShares ESG Aware MSCI EM ETF
ESGE
$6.81B
$131K 0.01%
+4,069
New +$138K
MRNA icon
480
Moderna
MRNA
$25.4B
$131K 0.01%
+914
New +$131K
SLYG icon
481
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.22B
$131K 0.01%
+1,862
New +$141K
IR icon
482
Ingersoll Rand
IR
$32.9B
$127K 0.01%
+3,028
New +$138K
GLW icon
483
Corning
GLW
$144B
$126K 0.01%
+3,983
New +$137K
MTG icon
484
MGIC Investment
MTG
$6.29B
$126K 0.01%
10,000
BGS icon
485
B&G Foods
BGS
$291M
$123K 0.01%
+5,180
New +$129K
FTV icon
486
Fortive
FTV
$18.6B
$121K 0.01%
+2,946
New +$130K
ANSS
487
DELISTED
Ansys
ANSS
$120K 0.01%
+502
New +$133K
CBAY
488
DELISTED
Cymabay Therapeutics
CBAY
$118K 0.01%
40,000
+10,000
+33% +$23.9K
PGEN icon
489
Precigen
PGEN
$2.45B
$115K 0.01%
+85,873
New +$127K
SGU icon
490
Star Group
SGU
$417M
$114K 0.01%
12,450
ESGD icon
491
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$113K 0.01%
+1,798
New +$123K
REGN icon
492
Regeneron Pharmaceuticals
REGN
$82.2B
$113K 0.01%
+192
New +$125K
TD icon
493
Toronto Dominion Bank
TD
$204B
$113K 0.01%
+1,718
New +$125K
XYZ
494
Block Inc
XYZ
$47B
$113K 0.01%
+1,832
New +$167K
CRSP icon
495
CRISPR Therapeutics
CRSP
$5.22B
$112K 0.01%
+1,850
New +$109K
EQR icon
496
Equity Residential
EQR
$24.2B
$112K 0.01%
+1,550
New +$123K
WEC icon
497
WEC Energy
WEC
$35.6B
$111K 0.01%
+1,099
New +$111K
BGT icon
498
BlackRock Floating Rate Income Trust
BGT
$330M
$110K 0.01%
10,000
HSY icon
499
Hershey
HSY
$37B
$109K 0.01%
+508
New +$111K
PFN
500
PIMCO Income Strategy Fund II
PFN
$706M
$109K 0.01%
13,700

Similar funds

Cary Street Partners Investment Advisory's Q2 2022 Portfolio in Review

As of Q2 2022, Cary Street Partners Investment Advisory held 567 positions worth $1.18B, up 224% from $364M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cary Street Partners Investment Advisory deployed $919M of net new capital in Q2 2022, opening 294 new positions and adding to 201 existing holdings. Its largest new stake was CME Group: 88,700 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Toyota, an estimated $824K trimmed.

  • Cary Street Partners Investment Advisory's largest Q2 2022 buy was CME Group: 88,700 shares worth $18.2M.
  • Cary Street Partners Investment Advisory added most to Apple in Q2 2022, an estimated $44.5M increase.
  • Cary Street Partners Investment Advisory's biggest Q2 2022 reduction was Toyota, cutting an estimated $824K.
  • Cary Street Partners Investment Advisory fully exited Invesco National AMT-Free Municipal Bond ETF in Q2 2022, selling an estimated $419K.
  • Cary Street Partners Investment Advisory's ten largest holdings make up 18% of its $1.18B portfolio in Q2 2022.
  • Cary Street Partners Investment Advisory opened 294 new positions and closed 16 in Q2 2022.
  • Cary Street Partners Investment Advisory's portfolio value rose 224% quarter-over-quarter to $1.18B.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.